Show simple item record

dc.contributor.authorWang, Pen_US
dc.contributor.authorLi, Xen_US
dc.contributor.authorWang, Jen_US
dc.contributor.authorGao, Den_US
dc.contributor.authorLi, Yen_US
dc.contributor.authorLi, Hen_US
dc.contributor.authorChu, Yen_US
dc.contributor.authorZhang, Zen_US
dc.contributor.authorLiu, Hen_US
dc.contributor.authorJiang, Gen_US
dc.contributor.authorCheng, Zen_US
dc.contributor.authorWang, Sen_US
dc.contributor.authorDong, Jen_US
dc.contributor.authorFeng, Ben_US
dc.contributor.authorChard, LSen_US
dc.contributor.authorLemoine, NRen_US
dc.contributor.authorWang, Yen_US
dc.date.accessioned2018-06-22T10:49:30Z
dc.date.issued2018-01-10en_US
dc.date.submitted2018-05-24T13:42:11.986Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/40043
dc.description.abstractThe originally published version of this Article contained errors in Figure 4. In panel b, the square and diamond labels associated with the uppermost survival curve were incorrectly displayed as 'n' and 'u', respectively. These errors have now been corrected in both the PDF and HTML versions of the Article.en_US
dc.format.extent203 - ?en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofNat Communen_US
dc.rightsCC BY
dc.titleAuthor Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.en_US
dc.typeArticle
dc.rights.holder(c) The Author(s) 2018.
dc.identifier.doi10.1038/s41467-017-02205-9en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29321470en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume9en_US
qmul.funderDevelopment of an effective therapeutic regimen for treatment of advanced pancreatic cancer using a novel immunotherapeutic agent::Medical Research Councilen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record